Residential Care

 

Michigan Changes to Moderna COVID Vaccine for LTC

 

Due to recent changes in supply, the Michigan Department of Health & Human Services (MDHHS) has requested and been approved by the Centers for Disease Control & Prevention (CDC) to change the vaccine source for long term care communities (LTC) to the Moderna vaccine. This change will significantly increase the vaccine supply quantities allocated to CVS & Walgreens as they roll out on-site clinics to LTC facilities.

  

So What Does This Mean?

The CDC has a webpage devoted to the Moderna COVID vaccine  that you may find helpful. LTC residents will be offered the Moderna COVID-19 Vaccine in replacement of the Pfizer COVID-19 Vaccine.

Residents and families may have questions related to the Moderna vaccine. The reality is that there is very little discernable difference in the chemical make-up between the Pfizer and Moderna vaccines. Both utilize mRNA technology as the basis of the vaccine neither vaccines contain the live virus. Both vaccines cause the immune system to create antibodies to ward off the virus.

The outcomes of the clinical trials between the Pfizer and Moderna vaccines are also almost identical. The effectiveness of each is comparable and the same side effects have been identified for both. These include tenderness and redness at the injection site, along with occasional mild fatigue, fever or headache.

The Moderna vaccine Emergency Use Authorization (EUA) was issued with a 28-day period between the first and second dose of vaccine. The second dose will be administered here at the facility 28 days after the initial dose.


NOCC On-Site Clinic:

An onsite clinic will be held here at NOCC for residents in the next 7-14 days.


We encourage you to review the EUA materials and contact the facility with questions. Please sign and return the consent you were provided this week in the mail authorizing the administration of the Moderna COVID-19 Vaccine.

Walgreens Consent Form 

Moderna Fact Sheet for Recipients and Caregivers